Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-22

Clinical Trial Update: Staged Phase I/II Hepatitis C Prophylactic Vaccine [Phase 1, Phase 2]

View source ↗

Summary

A staged Phase I/II clinical trial evaluated a prophylactic vaccine for Hepatitis C; status completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Hepatitis C | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-07-22